
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
An initial antiretroviral regimen containing four anti-HIV medications is not significantly better at suppressing viral levels or boosting CD4 counts than standard triple-drug treatment, according to study of 53 antiretroviral-naive adults in the United Kingdom. About 84% of study subjects taking four-drug therapy containing Trizivir and Sustiva for 48 weeks achieved viral-load levels of less than 50, and 77% of those taking three-drug therapy consisting of Combivir and Sustiva lowered their viral loads to below 50. Four-drug therapy boosted CD4 counts by an average of 185, compared to an average increase of 164 for those on the three-drug regimen. Based on these findings, the researchers say a standard initial three-drug regimen is just as clinically potent as those that include a fourth.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video